Initiatives and Summits

SITC is committed to taking a big tent approach involving all critical stakeholders in moving the field forward towards finding a cure for cancer. The US federal government is one of these critical stakeholders and impacts every aspect of the field of immunotherapy from basic research, regulatory approval, clinical care, and beyond. The SITC Policy Committee and Subcommittees are tasked with fostering SITC’s engagement with the federal government and establishing the Policy strategic priorities for the Society.